Vaccination with MVA/HIV induces differential recruitment of monocyte subsets into the circulation and monocyte-specific transcriptional programs

por Andersen-Nissen, E, Zak, DE, Hensley, TR, Adams, DJ, Hu, X, Sato, A, Elizaga, M, Goepfert, PA, Robinson, HL, Aderem, A, McElrath, MJ
Publicado 2012

First-in-human phase I clinical trial of a recombinant vesicular stomatitis virus (rVSV)-based preventive HIV-1 vaccine

por Fuchs, JD, Frank, I, Kochar, N, Elizaga, M, Allen, M, Carter, D, Frahm, N, Kalams, SA, Mulligan, M, Sheets, R, Pensiero, M, Clarke, D, Eldridge, J
Publicado 2012

Rapid development of cross-clade neutralizing antibody responses after clade B gp120/gp140 protein priming and clade c gp140 protein boosting

por Spearman, P, Tomaras, G, Montefiori, D, Huang, Y, Ahmed, H, Elizaga, M, Hural, J, McElrath, J, Ouedraogo, L, Pensiero, M, Butler, C, Kalams, S, Overton, ET, Barnett, S, Group, N
Publicado 2012

Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles

por Goepfert, P, Elizaga, M, Montefiori, D, Hural, J, DeRosa, S, Tomaras, G, Seaton, K, Sato, A, Ouedraogo, L, Donastorg, Y, Cardinali, M, Lama, J, Baden, L, Keefer, M, McElrath, J, Kalams, S, Robinson, H
Publicado 2012